All Outputs (3)

Scedosporium apiospermum brain abscesses in a patient receiving ibrutinib and venetoclax (2020)
Journal Article
Figueroa, R., Martinez‐Calle, N., Prescott, K., & Bishton, M. (2020). Scedosporium apiospermum brain abscesses in a patient receiving ibrutinib and venetoclax. eJHaem, 1(2), 418-419. https://doi.org/10.1002/jha2.121

An 80-year-old male, with relapsed mantle cell lymphoma was treated on a trial with the combination of the bruton tyrosine kinase (BTK) inhibitor, ibrutinib, and BH3-mimetic, venetoclax, and achieved complete remission by both Computerized Tomography... Read More about Scedosporium apiospermum brain abscesses in a patient receiving ibrutinib and venetoclax.

Extended follow‐up of CD4 + T cell recovery kinetics in a large cohort of patients with B‐cell lymphoproliferative disease treated with rituximab‐bendamustine (2020)
Journal Article
Gaiolla, R., Hartley, S., Beech, A., Knight, H., Smith, D., Bishton, M., …Martinez-Calle, N. (2021). Extended follow‐up of CD4 + T cell recovery kinetics in a large cohort of patients with B‐cell lymphoproliferative disease treated with rituximab‐bendamustine. Hematological Oncology, 39(1), 137-140. https://doi.org/10.1002/hon.2797

The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival (2020)
Journal Article
Bishton, M. J., Rule, S., Wilson, W., Turner, D., Patmore, R., Clifton‐Hadley, L., …Haynes, A. (2020). The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival. British Journal of Haematology, 190(4), 545-554. https://doi.org/10.1111/bjh.16555

We present a long-term follow-up of the UK chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced, symptomatic follicular lymphoma (FL). This trial was the first to prospecti... Read More about The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survival.